Recent advances in vaccines and diagnostics against Middle East respiratory syndrome coronavirus

Acta Virologica
|June 20, 2020
PubMed

Insights

Middle East respiratory syndrome coronavirus (MERS-CoV) poses a global threat due to its high mortality and human-to-human transmission. Early detection and vaccine development are crucial for controlling this severe respiratory illness.

Area of Science:

  • Virology
  • Epidemiology
  • Public Health

Background:

  • Middle East respiratory syndrome coronavirus (MERS-CoV), identified in 2012, causes severe respiratory disease with high mortality.
  • Over 2500 cases confirmed in 27 countries, with outbreaks like South Korea's 2015 event highlighting global transmission risks.

Purpose of the Study:

  • To review the transmission dynamics and infection process of MERS-CoV.
  • To summarize current scientific endeavors in developing vaccines and diagnostic tools for MERS-CoV.

Main Methods:

  • Literature review focusing on MERS-CoV epidemiology and virology.
  • Analysis of scientific publications on vaccine development and diagnostic strategies.

Main Results:

  • MERS-CoV exhibits significant mortality and potential for global spread through human-to-human transmission.
  • No licensed vaccine currently exists, underscoring the need for effective countermeasures.

Conclusions:

  • Early detection is paramount for limiting the spread of MERS-CoV.
  • Continued research into MERS-CoV transmission, infection, vaccines, and diagnostics is essential.